First Time Loading...
R

Remedy Entertainment Oyj
OMXH:REMEDY

Watchlist Manager
Remedy Entertainment Oyj
OMXH:REMEDY
Watchlist
Price: 18.72 EUR 14.15% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

REMEDY Price Targets Summary
Remedy Entertainment Oyj

Wall Street analysts forecast REMEDY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REMEDY is 22.1 EUR with a low forecast of 19.19 EUR and a high forecast of 28.35 EUR.

REMEDY Lowest Forecast
Wall Street Target
19.19 EUR
3% Upside
REMEDY Average Forecast
Wall Street Target
22.1 EUR
18% Upside
REMEDY Highest Forecast
Wall Street Target
28.35 EUR
51% Upside
Lowest
Price Target
19.19 EUR
3% Upside
Average
Price Target
22.1 EUR
18% Upside
Highest
Price Target
28.35 EUR
51% Upside
Remedy Entertainment Oyj Competitors:
Price Targets
C
CIG
CI Games SA
216% Upside
Z
600633
Zhejiang Daily Digital Culture Group Co Ltd
40% Upside
ALATA
Atari SA
456% Upside
9766
Konami Holdings Corp
14% Upside
C
CIG
CI Games SA
216% Upside
Z
600633
Zhejiang Daily Digital Culture Group Co Ltd
40% Upside
ALATA
Atari SA
456% Upside
9766
Konami Holdings Corp
14% Upside
3765
GungHo Online Entertainment Inc
10% Upside
S
9684
Square Enix Holdings Co Ltd
23% Upside
H
HUG
Huuuge Inc
46% Upside
7844
Marvelous Inc
18% Upside

Revenue
Forecast

Revenue Estimate
Remedy Entertainment Oyj

For the last 6 years the compound annual growth rate for Remedy Entertainment Oyj's revenue is 18%. The projected CAGR for the next 4 years is 14%.

18%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Remedy Entertainment Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Remedy Entertainment Oyj

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
REMEDY intrinsic value, competitors valuation, and company profile.
DCF Valuation
REMEDY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
REMEDY stock valuation using valuation multiples.
Wall Street Estimates
REMEDY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
REMEDY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REMEDY's stock price target?
Price Target
22.1 EUR

According to Wall Street analysts, the average 1-year price target for REMEDY is 22.1 EUR with a low forecast of 19.19 EUR and a high forecast of 28.35 EUR.

What is Remedy Entertainment Oyj's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Remedy Entertainment Oyj's revenue is 18%. The projected CAGR for the next 4 years is 14%.

ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.